March 2, 2018 Audience: Patient, Health Professional, Risk Manager [Posted 03/02/2018] ISSUE: FDA is alerting health care professionals and patients not to use drug products produced by Cantrell Drug Company of Little Rock, Arkansas, including opioid products and other drugs intended for sterile injection, that were produced by the company and distributed nationwide. The agency […]Continue Reading ...
March 2, 2018 New research has found no evidence Omega-3 fish oil supplements help aid or improve the reading ability or memory function of underperforming school-children. These findings are in contradiction to an earlier study run by the same team using the same supplement. In the second high-quality trial of its kind, published in PLOS-ONE, […]Continue Reading ...
March 1, 2018 Whether grilled, spicy with bell peppers or breaded in flour and fried floating in oil – the carp is one of the most popular edible fish. A dreaded threat to the up to 15 kilos fried fish: the koi herpes virus (KHV). It can be dormant in the carp for months before […]Continue Reading ...
PodMed is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso, look at the top medical stories of the week. This week’s topics include ruling out lung clots in the […]Continue Reading ...
February 23, 2018 Inflammation needs energy An important source for this energy is oxygen, which is indispensable for the cells of the immune system to work properly. On the one hand, oxygen is an essential element required for cells to survive; on the other hand, it also adds fuel to the fire of inflammation. Researchers […]Continue Reading ...
FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions BRIDGEWATER, N.J., Feb. 19, 2018 (GLOBE NEWSWIRE) — Osmotica Pharmaceutical US LLC (“Osmotica” or the “Company”), a privately-held specialty pharmaceutical company developing novel central nervous system (CNS) treatments utilizing its proprietary osmotic drug delivery platform, announced today that the U.S. […]Continue Reading ...
Action Points A year-long, multi-faceted, school-based obesity intervention program for young children 5 – 6 years of age failed to produce any significant results 15 and 30 months post-intervention, in a U.K. study. Note that the year-long obesity intervention program had 4 main components: moderate to vigorous physical activity, cooking classes for students and parents […]Continue Reading ...
February 6, 2018 Aortic aneurysm – the dilation of the aorta – is a serious condition that lacks effective drug treatment. Researchers at Karolinska Institutet in Sweden report in the journal PNAS, however, that a common asthma drug can retard the development of aortic aneurysm in mice. ”Our results are exciting and open the way […]Continue Reading ...
Lifestyle intervention can help reduce risk of gestational weight gain in expectant mothers, researchers reported. The two trials were part of the Lifestyle Interventions for Expectant Moms (LIFEMoms) consortium of seven clinical trials. In one study, a lifestyle program, including nutrition and physical activity intervention, reduced the amount of gestational weight gain versus usual obstetrical […]Continue Reading ...
fexapotide triflutate Treatment for Benign Prostatic Hyperplasia Nymox Announces US NDA for Fexapotide for BPH HASBROUCK HEIGHTS, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that the Company will submit a New Drug Application (NDA) for Fexapotide Triflutate for the treatment of BPH in the US. The Company has recently […]Continue Reading ...
Inflammation needs energy An important source for this energy is oxygen, which is indispensable for the cells of the immune system to work properly. Oxygen is an essential element required for cells to survive, but it also adds fuel to the fire of inflammation. Researchers from University of Erlangen-Nuremberg have discovered that the body uses […]Continue Reading ...
Action Points Long-term use of inhaled corticosteroids (ICS) at high doses was associated with a modest increase in risk for bone fractures in both men and women with chronic obstructive pulmonary disease (COPD). The study suggests that long-term ICS therapy in COPD leads to accelerated bone mineralization and increased risk of long-bone and vertebral fractures. […]Continue Reading ...
February 19, 2018 A clinical trial studying type 1 diabetes has reached full enrollment. The Sanford Project: T-Rex Study, a Phase 2 clinical trial conducted collaboratively by Sanford Health and Caladrius Biosciences, Inc., (Caladrius)(Nasdaq: CLBS), has completed enrollment of 110 children with type 1 diabetes. The study started with two sites at Sanford Health in […]Continue Reading ...
February 12, 2018 In a major advancement in nanomedicine, Arizona State University (ASU) scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST), of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply. “We have developed the first fully autonomous, DNA robotic […]Continue Reading ...
February 7, 2018 Medical devices and health care equipment are changing dramatically, and these new applications need innovative materials to bring them to life. For almost 50 years, OEMs have depended on advanced materials and expertise from Covestro LLC to bring life-saving and life-enhancing products to the health care market. The company’s portfolio of polycarbonate […]Continue Reading ...
- Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
- NeoTract presents new clinical data from studies of UroLift System for patients with BPH
- Statins Improve Long-Term Survival After AAA Repair
- Novel brain network linked to chronic pain in Parkinson’s disease
- Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
- Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
- FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
- IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
- Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
- How to Protect Your Eyesight
- Novel approach allows researchers to define how cells in the retina respond to diabetes
- Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
- Clinical trial investigators found non-compliant with requirement to report results on EU register
- U.S. Alzheimer’s Cases to Nearly Triple by 2060
- Improving cell replacement therapy for Parkinson’s disease
- Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
- FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
- New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks
- Researchers analyze response to combination immunotherapy for patients with rare skin cancer
- Study sheds light on how brain protein may be involved neurodevelopmental disorders